Literature DB >> 9623003

Age of disease onset influences cognition in Parkinson's disease.

H L Katzen1, B E Levin, M L Llabre.   

Abstract

It is controversial whether age of disease onset is related to cognitive decline in Parkinson's disease (PD). We administered 7 cognitive measures assessing visuospatial skills, memory, and executive functions to 222 patients with idiopathic PD and 108 normal control participants. Regression analyses demonstrated that older age of disease onset consistently predicted cognitive decline above and beyond normative aging and duration of illness. These findings suggest that older age of disease onset is a critical determinant of cognitive deterioration in PD.

Entities:  

Mesh:

Year:  1998        PMID: 9623003

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  10 in total

1.  Neuropsychology, neuroimaging or motor phenotype in diagnosis of Parkinson's disease-dementia: which matters most?

Authors:  Francesca Di Biasio; Nicola Vanacore; Alfonso Fasano; Nicola Modugno; Barbara Gandolfi; Francesco Lena; Giovanni Grillea; Sara Pietracupa; Giovanni Caranci; Stefano Ruggieri
Journal:  J Neural Transm (Vienna)       Date:  2011-12-13       Impact factor: 3.575

2.  Randomized trial of cognitive speed of processing training in Parkinson disease.

Authors:  Jerri D Edwards; Robert A Hauser; Melissa L O'Connor; Elise G Valdés; Theresa A Zesiewicz; Ergun Y Uc
Journal:  Neurology       Date:  2013-09-06       Impact factor: 9.910

3.  Paired-pulse inhibition in the auditory cortex in Parkinson's disease and its dependence on clinical characteristics of the patients.

Authors:  Elena Lukhanina; Natalia Berezetskaya; Irina Karaban
Journal:  Parkinsons Dis       Date:  2010-11-01

4.  Cognitive impairment in Parkinson's disease without dementia: subtypes and influences of age.

Authors:  Jae Woo Kim; Sang Myung Cheon; Min Jeong Park; Seong Yeon Kim; Hee Young Jo
Journal:  J Clin Neurol       Date:  2009-09-30       Impact factor: 3.077

5.  Epidemiology and neuropsychiatric manifestations of Young Onset Parkinson's Disease in the United States.

Authors:  A W Willis; M Schootman; N Kung; B A Racette
Journal:  Parkinsonism Relat Disord       Date:  2012-10-17       Impact factor: 4.891

6.  Are verbal fluency and nonliteral language comprehension deficits related to depressive symptoms in Parkinson's disease?

Authors:  Christina Tremblay; Oury Monchi; Carol Hudon; Joël Macoir; Laura Monetta
Journal:  Parkinsons Dis       Date:  2012-02-12

7.  Sorbus alnifolia protects dopaminergic neurodegeneration in Caenorhabditis elegans.

Authors:  Se-Myeong Cheon; Insoo Jang; Myon-Hee Lee; Dae Keun Kim; Hoon Jeon; Dong Seok Cha
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

8.  Sequence of clinical and neurodegeneration events in Parkinson's disease progression.

Authors:  Neil P Oxtoby; Louise-Ann Leyland; Leon M Aksman; George E C Thomas; Emma L Bunting; Peter A Wijeratne; Alexandra L Young; Angelika Zarkali; Manuela M X Tan; Fion D Bremner; Pearse A Keane; Huw R Morris; Anette E Schrag; Daniel C Alexander; Rimona S Weil
Journal:  Brain       Date:  2021-04-12       Impact factor: 15.255

9.  The relationships between mild cognitive impairment and phenotype in Parkinson's disease.

Authors:  Jennifer Yy Szeto; Claire O'Callaghan; James M Shine; Courtney C Walton; Loren Mowszowski; Sharon L Naismith; Glenda M Halliday; Simon Jg Lewis
Journal:  NPJ Parkinsons Dis       Date:  2015-08-27

Review 10.  LRRK2 at the Crossroad of Aging and Parkinson's Disease.

Authors:  Eun-Mi Hur; Byoung Dae Lee
Journal:  Genes (Basel)       Date:  2021-03-29       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.